Suchen und Finden
Front cover
1
HIV prevention: A comprehensive approach
4
Copyright page
5
Contents
8
Foreword
12
About the editors
18
Notes on contributors
20
Acknowledgments
40
Introduction
42
Part I: Epidemiological and biological issues in HIV prevention
50
Chapter 1 Current and future trends: implications for HIV prevention
52
Estimates and projections: methodology and refinements
54
Sub-pandemics in different world regions
55
Conceptual framework for HIV prevention
58
Multimodality of risk factors and impact on prevention interventions
61
Future trends
64
Conclusions
65
References
65
Chapter 2 Understanding the biology of HIV-1 transmission: the foundation for prevention
72
The assault force: HIV in genital secretions
73
Establishing a beachhead: the cellular organization of genital tract and rectal tissues, and early events in HIV sexual transmission
78
Summary and future directions
85
References
86
Chapter 3 HIV vaccines
94
Transmission and immunology of HIV and associated vaccine challenges
95
Challenges for HIV vaccine development
97
Vaccine approaches and evaluations
100
Vaccine candidates
102
Vaccine trials
109
The future of HIV vaccine efforts
120
Conclusions
121
Acknowledgment
121
References
122
Chapter 4 Microbicides
126
The biological rationale for microbicides
127
Microbicide development
129
The microbicide pipeline
132
Challenges to microbicide development
134
Socio-cultural perspectives on trial conduct in the developing world
137
Microbicides as part of the broader prevention agenda
141
Providing access to microbicides
143
Microbicide development remains a critical component of HIV prevention research
144
References
144
Chapter 5 Using antiretrovirals to prevent HIV transmission
148
HIV transmission
148
HIV in genital secretions
149
ART pharmacology
150
ART to Prevent Transmission of HIV
153
ART for post-exposure prophylaxis (PEP)
156
Clinical studies of non-occupational post-exposure prophylaxis
159
Pre-exposure prophylaxis to prevent HIV transmission
164
ART as public health prevention
167
ART and sexual behaviors: non-occupational post-exposure prophylaxis
169
ART resistance
172
Possible future strategies for ART as prevention: acute HIV infection
172
Conclusions
174
Acknowledgments
175
References
175
Chapter 6 Male circumcision and HIV prevention
187
Observational data on male circumcision and heterosexual HIV acquisition in men
187
Male circumcision and HIV acquisition in men who have sex with men
189
Randomized trials of male circumcision for HIV prevention in men
190
Biological evidence for the protective effects of circumcision for HIV prevention in men
193
Circumcision and STI acquisition in men
195
Male circumcision and HIV/STI infections in women
197
The safety of male circumcision
198
The prevalence and acceptability of male circumcision
199
Male circumcision and behavioral disinhibition or risk compensation
200
Modeling of the effects of male circumcision on population HIV incidence, the number of surgeries and cost per HIV infection averted
200
Scale-up of circumcision programs
201
References
203
Part II: Behavioral issues in HIV prevention
208
Chapter 7 Payoff from AIDS behavioral prevention research
210
Periods in AIDS prevention research
212
Conclusions
236
Acknowledgments
237
References
237
Chapter 8 Individual interventions
244
Stage 1: Common theoretical models applicable to individual interventions for HIV prevention
246
Stage 2: Selected efficacy trials of HIV prevention interventions based on the conceptual models
254
Stage 3: Summary and conclusions
273
Acknowledgment
276
References
276
Chapter 9 Couples' voluntary counseling and testing
281
Prevention through behavior change remains the best tool to control the epidemic
281
CVCT and correct and consistent condom use: what is known to work at the dyad level
282
Towards sustainable HIV prevention: structural and economic aspects, psychosocial elements, and social norms
285
Controversies: past and present
290
Best practices: a day in the life of a same-day CVCT clinic
292
Monitoring and evaluation of CVCT services
296
Twenty years of barriers and progress/concrete gains as CVCT evolves
298
Conclusion
300
References
301
Chapter 10 Updating HIV prevention with gay men: current challenges and opportunities to advance health among gay men
308
What is the evidence base for efficacy of HIV prevention efforts among gay men?
310
What are the current challenges in HIV prevention work among gay men?
311
Community viral load approaches to HIV prevention: reducing risk by changing context
315
How can we translate efficacy into effectiveness?
316
Towards a prevention cocktail: strategies to move HIV prevention among gay men forward
317
Steps toward the creation of a prevention cocktail
319
References
320
Chapter 11 Reducing sexual risk behavior among men and women with HIV infection
322
Sexual behavior among PLWHA
323
Intervention research addressing reduction in HIV transmission risk among PLWHA
329
Integration of HIV prevention programs into the clinical setting
336
Conclusions
339
References
340
Chapter 12 Injection drug use and HIV: past and future considerations for HIV prevention and interventions
346
Political and social context of injection drug use
346
Epidemiology of HIV infection among IDUs
348
Factors that have informed prevention and intervention strategies
353
Successful and unsuccessful interventions
362
Future directions
371
Acknowledgment
372
References
372
Chapter 13 HIV risk and prevention for non-injection substance users
381
Types of interventions used to treat substance use problems
383
Alcohol
385
Non-alcohol substance use
389
Use of other substances and HIV risk
398
Conclusions
401
References
401
Chapter 14 Preventing HIV among sex workers
417
Epidemiology, HIV risk and vulnerability among sex workers
418
Elements of effective interventions
426
The intervention gap and the need to scale up sex-worker interventions
434
Model programs from around the world
436
Challenges for setting up HIV prevention programs for sex workers
439
References
440
Chapter 15 Interventions with youth in high-prevalence areas
448
Epidemiology of HIV infection in youth
450
Young women and sexual risk
451
Reducing HIV risk
457
HIV prevention interventions in youth
461
Lessons learned from interventions targeted at youth
475
Conclusion
476
References
477
Chapter 16 Interventions with incarcerated persons
485
Epidemiology: the epidemic of incarceration in the United States
485
Prevention interventions
490
HIV/AIDS in international prisons
503
Future directions
505
Acknowledgments
506
References
506
Chapter 17 Preventing mother-to-child transmission of HIV
513
Progress in preventing mother-to-child transmission of HIV
514
Factors affecting mother-to-child transmission
514
Principles of prevention of MTCT: a comprehensive approach
515
Preventing mother-to-child transmission in high-resource settings: PMTCT advances
517
Preventing MTCT in low-resource settings: advances
519
Infant feeding: mother-to-child transmission through breastfeeding
524
From research to implementation
529
References
529
Part III: Structural and technical issues in HIV prevention
540
Chapter 18 Harm reduction, human rights and public health
542
Review of harm reduction interventions among vulnerable populations
545
The HIV epidemic among sex workers
548
The HIV epidemic among MSM
550
The HIV epidemic among incarcerated populations
552
Interplay between harm reduction, human rights and public health
554
Discussion
557
References
558
Chapter 19 HIV testing and counseling
565
History of HIV testing and counseling
565
HIV testing and counseling and behavior change
568
HIV testing and counseling models
572
Expanding HIV testing and counseling to reach specific populations
576
Continuing challenges and emerging issues
581
Advancing HIV testing and counseling
584
References
585
Chapter 20 Structural interventions in societal contexts
591
Venue-based approaches: wine shops to red-light districts
591
Social-network based approaches: prevention targeted at negotiating safe sex
593
Daughters, wives, and mothers: the impact of subordinating women in the home and community
595
Socially-driven public health responses
600
Targeting the individual in HIV prevention: condoms and antiretrovirals
604
Socially relevant HIV prevention
607
References
608
Chapter 21 Evaluating HIV/AIDS programs in the US and developing countries
612
Issues in defining the evaluation design
612
Types of summative evaluation
615
Major challenges in evaluating HIV/AIDS programs
627
Conclusion
630
References
630
Chapter 22 Adapting successful research studies in the public health arena: going from efficacy trials to effective public health interventions
632
Evaluating efficacy, effectiveness, and impact of biological interventions on HIV and STI incidence
633
Evaluating efficacy, effectiveness, and impact of behavioral interventions on HIV and STI risk behavior
636
Promoting the successful implementation of science-based HIV prevention: the CDC's approach
637
Emerging issues and challenges
646
Conclusions
651
Acknowledgment
653
Disclaimer
653
References
653
Index
660
A
660
B
662
C
664
D
668
E
668
F
670
G
670
H
671
I
673
J
675
K
675
L
676
M
676
N
678
O
680
P
680
R
682
S
683
T
687
U
688
V
689
W
691
Y
691
Z
692
Alle Preise verstehen sich inklusive der gesetzlichen MwSt.